Beli & Jual Kalbe Farma Tbk - KLBF Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp35,32 T | +8.27% |
| Cost of Revenue | Rp21,27 T | +8.13% |
| Gross Profit | Rp14,06 T | +8.48% |
| General Expenses, Depreciation, Interest | Rp9,42 T | +7.17% |
| Operating Profit | Rp4,64 T | +11.24% |
| Other Income | -Rp39 M | -69.96% |
| EBT | Rp4,78 T | +13.26% |
| Taxes | -Rp1,03 T | +6.36% |
| Net Income | Rp3,66 T | +13.1% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp30,7 T | +4.31% |
| Total Liabilities | Rp5,97 T | +23.38% |
| Total Equity | Rp23,31 T | +2.3% |
| Total Liabilities & Total Equity | Rp29,28 T | +5.99% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp3,27 T | -31.65% |
| CF from Investment | Rp799,89 M | -35.87% |
| CF from Financing | Rp2,87 T | +37.16% |
| Net Cash Flow | Rp398,52 M | -127.56% |